COMPARISON OF PURE ANTIBODY-MEDIATED REJECTION WITH MIXED CELLULAR AND ANTIBODY-MEDIATED REJECTION IN REGARDS TO THE PATHOLOGICAL FEATURES, DEVELOPMENT OF CARDIAC ALLOGRAFT VASCULOPATHY (CAV) AND CARDIOVASCULAR MORTALITY (CVM) IN HEART TRANSPLANT PATIENTS. Issue 3 (September 2020) - Ozdemir, B. Handan; Terzi, Aysen; Ayva, Sebnem; Sade, L. Elif; Basturk, Bilkay; Sezgin, Atilla